Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
暂无分享,去创建一个
C. Benoist | J. Allison | D. Mathis | P. Höglund | F. Lühder | Fred Lühder | Petter Höglund | James P. Allison | Petter Höglund | James P. Allison
[1] M. Mattéi,et al. Genetic control of diabetes progression. , 1997, Immunity.
[2] J. Allison,et al. Co-stimulation in T cell responses. , 1997, Current opinion in immunology.
[3] Yan Wu,et al. CTLA-4–B7 Interaction Is Sufficient to Costimulate T Cell Clonal Expansion , 1997, The Journal of experimental medicine.
[4] T. Strom,et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. , 1997, Immunity.
[5] J. Bluestone. Is CTLA-4 a master switch for peripheral T cell tolerance? , 1997, Journal of immunology.
[6] A. Sharpe,et al. Costimulation and autoimmunity. , 1996, Current opinion in immunology.
[7] M. Allen,et al. Human Influence on the Atmospheric Vertical Temperature Structure: Detection and Observations , 1996, Science.
[8] J. Allison,et al. The Role of CTLA‐4 in the Regulation and Initiation of T‐Cell Responses , 1996, Immunological reviews.
[9] E. Fuchs,et al. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. , 1996, Immunity.
[10] C. June,et al. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. , 1996, Journal of immunology.
[11] Nitin J. Karandikar,et al. CTLA-4: a negative regulator of autoimmune disease , 1996, The Journal of experimental medicine.
[12] J. Todd,et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. , 1996, Human molecular genetics.
[13] J. Bluestone,et al. CTLA-4 ligation blocks CD28-dependent T cell activation [published erratum appears in J Exp Med 1996 Jul 1;184(1):301] , 1996, The Journal of experimental medicine.
[14] J. Allison,et al. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells , 1996, The Journal of experimental medicine.
[15] T. Mak,et al. Regulation of T Cell Receptor Signaling by Tyrosine Phosphatase SYP Association with CTLA-4 , 1996, Science.
[16] R. Tisch,et al. Insulin-Dependent Diabetes Mellitus , 1996, Cell.
[17] T. Sullivan,et al. Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. , 1996, International immunology.
[18] J. Allison,et al. Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.
[19] C. Benoist,et al. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[20] H. Griesser,et al. Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.
[21] J. Bluestone,et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.
[22] R. Karr,et al. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. , 1995, Journal of immunology.
[23] J. Allison,et al. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation , 1995, The Journal of experimental medicine.
[24] C Benoist,et al. T helper cell subsets in insulin-dependent diabetes. , 1995, Science.
[25] J. Bluestone,et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse , 1995, The Journal of experimental medicine.
[26] P. Linsley,et al. CTLA-4 can function as a negative regulator of T cell activation. , 1994, Immunity.
[27] J. Bach,et al. Insulin-dependent diabetes mellitus as an autoimmune disease. , 1994, Endocrine reviews.
[28] C. Benoist,et al. Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.
[29] P. Linsley,et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes , 1992, The Journal of experimental medicine.
[30] J. Allison,et al. Identification and distribution of the costimulatory receptor CD28 in the mouse. , 1992, Journal of immunology.
[31] D. Gray,et al. Mice lacking MHC class II molecules , 1991, Cell.
[32] K. Haskins,et al. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. , 1990, Science.
[33] C. Benoist,et al. MHC-linked protection from diabetes dissociated from clonal deletion of T cells. , 1990, Science.